FUSION ANTIBODIES
Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully ... humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.
FUSION ANTIBODIES
Industry:
Biotechnology Clinical Trials Health Diagnostics Manufacturing Pharmaceutical
Founded:
2001-01-01
Address:
Belfast, Belfast, United Kingdom
Country:
United Kingdom
Website Url:
http://www.fusionantibodies.com
Total Employee:
11+
Status:
Active
Contact:
+44 28 9043 2800
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx
Similar Organizations
GlycoVaxyn
GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-05-23 | Selexis SA | Selexis SA acquired by Fusion Antibodies | N/A |
Investors List
Invest Northern Ireland
Invest Northern Ireland investment in Grant - Fusion Antibodies
Invest Northern Ireland
Invest Northern Ireland investment in Venture Round - Fusion Antibodies
University Challenge Fund
University Challenge Fund investment in Venture Round - Fusion Antibodies
Clarendon Fund Managers
Clarendon Fund Managers investment in Venture Round - Fusion Antibodies
Crescent Capital
Crescent Capital investment in Venture Round - Fusion Antibodies
QUBIS
QUBIS investment in Venture Round - Fusion Antibodies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-28 | Fusion Antibodies Appoints Adrian Kinkaid CEO Effective Aug. 15 |
Official Site Inspections
http://www.fusionantibodies.com
- Host name: 104.248.167.225
- IP address: 104.248.167.225
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Fusion Antibodies"
Company Profile - Fusion Antibodies
Fusion Antibodies is a Belfast based, revenue generating and profitable CRO providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and …See details»
Fusion Antibodies - 2025 Company Profile - Tracxn
Jun 12, 2025 Fusion Antibodies is a contract research organization offering a range of services in the antibody drug discovery and development space. The company's two antibodies are in …See details»
Fusion Antibodies Plc:Company Profile & Technical …
Fusion Antibodies Plc is a company that provides Monoclonal antibody, Medicine, Clinical trial and more. Fusion Antibodies Plc is headquartered in United Kingdom Belfast.See details»
Fusion Antibodies - Crunchbase Company Profile & Funding
Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and …See details»
R&D Antibody Discovery Partner | Fusion Antibodies
“One of the humanized antibodies you designed for us has excellent function and has undergone GMP production with a highly experienced CMO. According to this CMO, the antibody is the …See details»
Corporate Governance - Fusion Antibodies
Jul 26, 2024 Principles of Corporate Governance. Compliance with the QCA Code is set out in broad terms below on a “comply or explain basis”. Like all aspects of the QCA Code, …See details»
LSE:FAB - Revolutionising Antibody Development: Fusion's …
In the second instalment of our "Unveiling Fusion Antibodies" series, CEO Adrian Kinkaid delves into Fusion's commercial model and the strategic partnerships that drive their success. Here's …See details»
Fusion Antibodies - Overview, News & Similar companies
Aug 24, 2023 Fusion Antibodies contact info: Phone number: +44 2890432800 Website: www.fusionantibodies.com What does Fusion Antibodies do? Fusion is a Belfast based …See details»
Fusion Antibodies: quality by design - Nature
ADVERTISEMENT FEATURE ADVERTISER RETAINS SOLE RESPONSIBILITY FOR CONTENT FusionAntibodies www.fusionantibodies.com Fusion Antibodies: quality by designSee details»
Fusion Antibodies: Quality By Design
Sep 21, 2022 As an R&D-partnering organization with extensive expertise in antibody discovery and engineering, Fusion Antibodies’ approach and understanding of different antibody …See details»
Fusion Antibodies - PharmaSource
Fusion Antibodies is committed to advancing therapeutic and diagnostic solutions through cutting-edge technology and expertise in antibody work. For further details, please visit …See details»
Investor Relations - Fusion Antibodies - World Leading Antibody …
Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.See details»
Fusion Antibodies | VentureRadar
Website: http://www.fusionantibodies.com/ Provides comprehensive antibody discovery services, supporting therapeutic development from initial concept to clinical ...See details»
Company Information - Fusion Antibodies
The Company was incorporated and registered in Northern Ireland with registered number NI039740. It's main country of operation is Northern Ireland.See details»
Corporate News & RNS - Fusion Antibodies - Contract Win
Feb 27, 2025 www.fusionantibodies.com : Adrian Kinkaid, Chief Executive Officer Stephen Smyth, Chief Financial Officer: Via Walbrook PR : Allenby Capital Limited: Tel: +44 (0) 20 …See details»
Antibody Discovery - Fusion Antibodies
Fusion Antibodies will help select the host species that is best suited to generating the type of antibody you need. Whether exploiting the rich diversity, affinity and specificity of rabbit B-cell …See details»
Contact Us - Fusion Antibodies
Hi, like all websites we use cookies! Cookies allow us to help make your time on our website a better experience for you and allow us to offer you services like contact forms, play videos …See details»
News - Fusion Antibodies
Feb 10, 2023 Hi, like all websites we use cookies! Cookies allow us to help make your time on our website a better experience for you and allow us to offer you services like contact forms, …See details»
News and Insights - Fusion Antibodies
Feb 10, 2023 News and Insights from Fusion Antibodies. Read our latest news and insights to keep on top of the latest antibody discovery and development research and industry news.See details»